Publication date: Jul 27, 2026
This report details two cases presenting as vaccine injuries following mRNA COVID-19 vaccination. The first case involved a 65-year-old female who experienced dermatitis and was subsequently diagnosed with underlying tickborne diseases including Borrelia, Bartonella, Anaplasmosis, and their associated symptoms. The second case presented a 69-year-old male with cognitive impairment, insomnia, and chronic pain following vaccination, revealing elevated Epstein-Barr virus titers, lime positivity, and other tickborne infections. Both patients initially responded to LDN treatment alongside targeted therapies for their identified underlying conditions, highlighting the importance of comprehensive diagnostics beyond standard protocols when addressing vaccine injury cases.
| Concepts | Keywords |
|---|---|
| 65year | Chronic |
| Ceo | Covid |
| Deer | Dermatitis |
| Dermatitis | Dose |
| Vaccine | History |
| Injury | |
| Ldn | |
| Old | |
| Pain | |
| Sleep | |
| Underlying | |
| Vaccine | |
| Visit | |
| Www | |
| Year |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Naltrexone |
| disease | MESH | injury |
| disease | MESH | chronic conditions |
| disease | MESH | dermatitis |
| disease | MESH | tick-borne diseases |
| disease | MESH | pain |
| disease | MESH | Lyme disease |
| disease | MESH | infections |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Cancers |
| disease | MESH | Chronic Pain |
| disease | MESH | Mona |
| disease | MESH | itching |
| drug | DRUGBANK | Tropicamide |
| drug | DRUGBANK | Spinosad |
| disease | MESH | cognitive impairment |
| disease | MESH | memory loss |
| disease | MESH | fatigue |
| drug | DRUGBANK | Ozone |
| disease | MESH | insomnia |
| disease | MESH | chronic regional pain syndrome |
| disease | MESH | relapsing fever |